Skip to main content

Table 3 Analysis of associations between TGFB codon 10 T/C and codon 25G/C polymorphisms and risk of HAM/TSP development

From: Lack of association between single-nucleotide polymorphisms of pro- and anti-inflammatory cytokines and HTLV-1-associated myelopathy / tropical spastic paraparesis development in patients from Rio de Janeiro, Brazil

Polymorphisms

HAM/TSP

Asymptomatic

  

n (%)

n (%)

OR (IC:95%)

p-value

TGFB Codon 10

 T/T

25 (37.3)

24 (28.9)

1

 

 T/C

29 (43.3)

45 (54.2)

0.62 (0.3–1.28)

 

 C/C

13 (19.4)

14 (16.9)

0.89 (0.35–2.29)

0.61

 Alleles

  T

79 (59.0)

93 (55.4)

1

 

  C

55 (41.0)

73 (43.5)

0.89 (0.56–1.41)

0.70

TGFB Codon 25

 G/G

56 (83.6)

71 (85.5)

1

 

 G/C

10 (14.9)

11 (13.3)

1.15 (0.45–2.92)

 

 C/C

1 (1.5)

1 (1.2)

1.27 (0.05–32.54)

0.74

 T/C G/G High

47 (70.1)

58 (69.9)

1

 

 T/C G/C; C/C G/G; T/T G/C Intermediate

15 (22.4)

24 (28.9)

0.77 (0.36–1.62)

 

 C/C G/C; C/C C/C; T/T C/C Low

5 (7.5)

1 (1.2)

6.17 (0.95–120.4)

0.51

  1. HAM/TSP HTLV-1 associated myelopathy tropical spastic paraparesis, Asymptomatic HTLV-1 patients, OR odds ration with confident interval, Chi-square 2 × 2 or 3 × 2 contingent tables, Fisher exact or Cochran-Armitage tests